<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title>Mediators of Inflammation</journal-title><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1155/2007/31397</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Serum IL-1<inline-formula><mml:math id="M1"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M2"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> Levels in Early Diagnosis and Management of Neonatal Sepsis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kurt</surname><given-names>A. Nese Citak</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Aygun</surname><given-names>A. Denizmen</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Godekmerdan</surname><given-names>Ahmet</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kurt</surname><given-names>Abdullah</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dogan</surname><given-names>Yasar</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yilmaz</surname><given-names>Erdal</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Pediatrics, Faculty of Medicine, Firat University, Elazig 23119, Turkey</aff><aff id="I2"><sup>2</sup>Department of Immunology, Faculty of Medicine, Firat University, Elazig 23119, Turkey</aff><author-notes><corresp id="cor1">*A. Nese Citak Kurt: <email>nkurt@firat.edu.tr</email></corresp></author-notes><pub-date pub-type="ppub"><year>2007</year></pub-date><pub-date pub-type="epub"><day>10</day><month>1</month><year>2008</year></pub-date><volume>2007</volume><elocation-id>31397</elocation-id><history><date date-type="received"><day>10</day><month>5</month><year>2007</year></date><date date-type="accepted"><day>31</day><month>10</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 A. Nese Citak Kurt et al.</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p><italic>Aim</italic>. To determine serum IL-1<inline-formula><mml:math id="M3"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M4"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels in neonatal sepsis at the time of diagnosis and after therapy, and to show the meaningful on the follow up. <italic>Methods</italic>. This prospective study was performed on newborns who were hospitalized for neonatal sepsis and who were classified as culture-proven sepsis (<inline-formula><mml:math id="M5"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>12</mml:mn></mml:mrow></mml:math></inline-formula>), as culture-negative sepsis (<inline-formula><mml:math id="M6"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>21</mml:mn></mml:mrow></mml:math></inline-formula>), and as healthy newborns (<inline-formula><mml:math id="M7"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>17</mml:mn></mml:mrow></mml:math></inline-formula>). <italic>Results</italic>. At the time of diagnosis, serum IL-1<inline-formula><mml:math id="M8"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M9"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels of culture-proven sepsis were significantly higher than those of the control groups (<inline-formula><mml:math id="M10"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula>). At the time of diagnosis, IL-1<inline-formula><mml:math id="M11"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M12"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels of culture-proven sepsis and culture-negative sepsis were significantly higher than levels at the seventh day after antibiotic treatment. <italic>Conclusion</italic>. Serum IL-1<inline-formula><mml:math id="M13"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M14"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> are mediators of inflammation and can be used at the diagnosis and at the evaluation of the therapeutic efficiency in neonatal sepsis.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>Bacterial infection in newborns, especially preterm, may rapidly evolve into generalized sepsis. This condition has a gradual and subtle onset, with nonspecific symptoms that may severely compromise the infant&#x02019;s clinical state if untreated and lead to life-threatening consequences. Neonatal sepsis has a fairly low incidence at birth (1&#x02013;10/1000 live births) but may affect up to 16% of infants in the neonatal intensive care unit (NICU) with birth weight of 501&#x02013;1500&#x02009;gm. The mortality rate is very high: 15&#x02013;50% of affected infants [<xref ref-type="bibr" rid="B1">1</xref>].</p><p>Clinical manifestations are nonspecific and laboratory parameters such as white blood cell (WBC) count or C-reactive protein (CRP) are of limited value in identifying infected newborns. As a consequence, appropriate diagnosis and therapy could be delayed, worsening the prognosis of the patient [<xref ref-type="bibr" rid="B2">2</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>].</p><p>In studies elsewhere [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>], the WBC count showed a low detection sensitivity in neonatal infection. Even the combination of total neutrophil count, immature-to-total neutrophil ratio (I/T), and platelet count failed to reach an appropriate sensitivity and specifity in this pathology. C-reactive protein has been thoroughly studied as a diagnostic tool in neonatal sepsis and also as an indicator of response to therapy [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>].</p><p>The underdeveloped immune system predisposes preterm newborns to infection, which is a major cause of neonatal morbidity and mortality. Sepsis and endotoxin activate monocytes, macrophages, lymphocytes, fibroblasts, and endothelial cells that produce and secrete IL-1, TNF-<inline-formula><mml:math id="M15"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M16"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>-interferon, IL-6, IL-8, and other proinflammatory cytokines. IL-6, stimulated by TNF-<inline-formula><mml:math id="M17"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-1, and endotoxin of viral and bacterial infections, acts as a T-cell activation indicator, induces antibody secretion by human B-cells, causes differentiation of cytotoxic T-cells, and also has the ability to inhibit TNF-<inline-formula><mml:math id="M18"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> production. Moreover, IL-6 is the major stimulant in hepatic protein synthesis, that is, CRP and fibrinogen during acute phase responses. Previous studies have shown that determinations of IL-6 in neonatal blood are of diagnostic value in sepsis. Elevated serum IL-1<inline-formula><mml:math id="M19"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M20"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels have been found in both the neonatal and adult sepsis. Several studies have evaluated the role of cytokine determinations as early diagnostic markers in neonatal sepsis [<xref ref-type="bibr" rid="B11">11</xref>&#x02013;<xref ref-type="bibr" rid="B17">17</xref>].</p><p>The aim of this study is to determine serum IL-1<inline-formula><mml:math id="M21"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M22"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels in neonatal sepsis at the time of diagnosis and after therapy and to show the meaningful on the follow up.</p></sec><sec sec-type="section" id="sec2"><title>2. MATERIAL AND METHODS</title><p>This prospective study was performed on newborns who were hospitalized for neonatal sepsis at NICU. Inclusion criteria were positive clinical signs of sepsis and/or history of factors associated with increased risk for infection and parental informed consent. Exclusion criteria were congenital malformations, congenital infections associated with the TORCH complex, and refusal of parental consent. Clinical signs of sepsis were defined as the presence of three or more of the following categories of clinical signs: apnea, tachypnea (<inline-formula><mml:math id="M23"><mml:mrow><mml:mo>&#x0003e;</mml:mo></mml:mrow></mml:math></inline-formula>60/min), nasalflaring, retraction, cyanosis, respiratory distress-bradycardia (<inline-formula><mml:math id="M24"><mml:mrow><mml:mo>&#x0003c;</mml:mo></mml:mrow></mml:math></inline-formula>100/min), tachycardia (<inline-formula><mml:math id="M25"><mml:mrow><mml:mo>&#x0003e;</mml:mo></mml:mrow></mml:math></inline-formula>180/min), hypotonia, seizures-poor skin colour, capillary refilling time longer than two seconds, irritability, and lethargy. Historical factors associated with increased risk for infection included premature rupture of the membranes (in term infants <inline-formula><mml:math id="M26"><mml:mrow><mml:mo>&#x0003e;</mml:mo></mml:mrow></mml:math></inline-formula>18 hours), maternal fever during labour, intraamniotic infection, and chorioamnionitis. Two or more abnormal values of the sepsis screen (as white blood cell count <inline-formula><mml:math id="M27"><mml:mrow><mml:mo>&#x0003c;</mml:mo></mml:mrow></mml:math></inline-formula>4000 or <inline-formula><mml:math id="M28"><mml:mrow><mml:mo>&#x0003e;</mml:mo></mml:mrow></mml:math></inline-formula>10.000&#x02009;mm<sup>3</sup>, immature-to-total neutrophil ratio higher than 0.2 and CRP positivity) were considered as supportive for diagnosis of infection [<xref ref-type="bibr" rid="B18">18</xref>]. Newborns were classified as culture-proven sepsis (positive blood culture), as culture-negative sepsis (negative blood culture, but clinical signs of sepsis with positive sepsis screen and/or a history of risk factors, and antibiotic treatment longer than 7 days), and as control groups (healthy, noninfectious newborns). Blood samples were obtained at time of diagnosis and seventh day after antibiotic treatment, their serum extracted and IL-1<inline-formula><mml:math id="M29"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M30"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> were determined.</p><p>Blood analysis was done in Firat Medical Center Immunology Laboratory (Elazig, Turkey). The local ethics commission approved the study.</p><p>CRP was determined by the Behring Nephelometer 100 Analyzer BN II (NY, USA). Detection limit was 3&#x02009;mg/L and a serum value of <inline-formula><mml:math id="M31"><mml:mrow><mml:mo>&#x0003e;</mml:mo></mml:mrow></mml:math></inline-formula>8&#x02009;mg/L was defined as abnormally elevated. The serum samples of the study and control groups were studied by ELISA for IL-1<inline-formula><mml:math id="M32"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M33"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels with human cytokine kits (Biosource, Calif, USA). Detection limit for serum IL-1<inline-formula><mml:math id="M34"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> level was 1&#x02009;pg/mL, measure range was 0&#x02013;250&#x02009;pg/mL. Detection limit for serum IL-6 level was 2&#x02009;pg/mL, measure range was 0&#x02013;500&#x02009;pg/mL. Detection limit for serum IL-8 level was 5&#x02009;pg/mL, measure range was 0&#x02013;1000&#x02009;pg/mL. Detection limit for serum TNF-<inline-formula><mml:math id="M35"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> level was 1.7&#x02009;pg/mL, measure range was 0&#x02013;1000&#x02009;pg/mL The collected blood samples were centrifuged at 2500&#x02009;g for 10 minutes at <inline-formula><mml:math id="M36"><mml:mrow><mml:mn>4</mml:mn><mml:mo>&#x000b0;</mml:mo></mml:mrow></mml:math></inline-formula>C. The serum layer was separated and frozen at <inline-formula><mml:math id="M37"><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>80</mml:mn><mml:mo>&#x000b0;</mml:mo></mml:mrow></mml:math></inline-formula>C for cytokine analysis, which was performed in less than 2 weeks. Freezing/thawing cycles were avoided.</p><p>Statistical analyses were performed using the SPSS 11.0 programs for Windowns XP. The results were done as mean <inline-formula><mml:math id="M38"><mml:mrow><mml:mo>&#x000b1;</mml:mo></mml:mrow></mml:math></inline-formula> standard deviation. Kruskal Wallis and post hoc test Scheffe procedures were used; the difference in three groups and <inline-formula><mml:math id="M39"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula> was considered to be significant. Wilcoxon test was used for the interpretation of the difference between at time of diagnosis and after therapy.</p></sec><sec sec-type="section" id="sec3"><title>3. RESULTS</title><p>In total, 50 newborns were included in the study: 12 culture-proven sepsis, 21 culture-negative sepsis, and 17 control. <xref ref-type="table" rid="tab1">Table 1</xref> shows the characteristics of the study group.</p><p>At time of diagnosis, serum IL-1<inline-formula><mml:math id="M40"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M41"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels of culture-proven sepsis were significantly higher than those of the control groups (<inline-formula><mml:math id="M42"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula>); but only serum IL-8 levels of culture-proven sepsis was significantly higher than culture-negative sepsis (<inline-formula><mml:math id="M43"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula>).</p><p>At time of diagnosis, serum IL-1<inline-formula><mml:math id="M44"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M45"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels of culture-proven sepsis and culture-negative sepsis were significantly higher than levels at seventh day after antibiotic treatment (<inline-formula><mml:math id="M46"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula>).</p><p>Serum IL-1<inline-formula><mml:math id="M47"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M48"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels were showed in <xref ref-type="table" rid="tab2">Table 2</xref>.</p></sec><sec sec-type="section" id="sec4"><title>4. DISCUSSION</title><p>Bacterial infection continues to be the major cause of morbidity and mortality in the newborn. Because the prognosis for sepsis largely depends on early identification and treatment, these newborns are subjected to extensive diagnostic evaluation and empirical systemic antibiotic treatment, pending laboratory results. The definitive diagnosis of sepsis is made by a positive blood culture, which requires a minimum of 48&#x02013;72 hours, yields a positive result in only 30&#x02013;70% of cases, and may not always be available in peripheral health centers. Several studies have examined the laboratory findings associated with sepsis [<xref ref-type="bibr" rid="B19">19</xref>&#x02013;<xref ref-type="bibr" rid="B21">21</xref>]. There is, however, a lack of consensus on the essential tests that would identify newborns with acute infection. Fowlie et al. [<xref ref-type="bibr" rid="B22">22</xref>] conducted a systematic review to determine the value of diagnostic tests for bacterial infection in early life (from birth to 90 days old) and reported that the accuracy of tests varies enormously and the tests are of limited value in the diagnosis of infection.</p><p>Hematological parameters have been evaluated in previous studies. Da Silva et al. [<xref ref-type="bibr" rid="B23">23</xref>] found significant heterogeneity across these studies. The possible sources of heterogeneity were population, age, whether the subjects were at term or preterm, methodological quality, different leukocyte indices, different cutoff values, and interpretation of test results by different laboratory observers.</p><p>In the past few decades, it has been observed that several mediators of inflammation tend to become elevated during sepsis. The concentrations of some proinflammatory cytokines, especially TNF-<inline-formula><mml:math id="M49"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, and IL-8, in systemic circulation were reported to increase in severe infections and septic shock [<xref ref-type="bibr" rid="B24">24</xref>]. Martin et al. [<xref ref-type="bibr" rid="B17">17</xref>] showed that serum IL-6, IL-8, and TNF-<inline-formula><mml:math id="M50"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels were all higher in septic than in nonseptic newborns.</p><p>The study of IL-1<inline-formula><mml:math id="M51"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M52"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, cytokines that are synthesized at the beginning of the inflammatory cascade has rendered differing results. In our study, the serum TNF-<inline-formula><mml:math id="M53"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> and IL-1<inline-formula><mml:math id="M54"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> levels were significantly increased in newborns with sepsis. Results of different published studies relation to these cytokines are contradictory. Concerning IL-1<inline-formula><mml:math id="M55"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> results, similar to ours, they have been reported by some researchers while not by others [<xref ref-type="bibr" rid="B25">25</xref>&#x02013;<xref ref-type="bibr" rid="B28">28</xref>]. Publishing data regarding TNF-<inline-formula><mml:math id="M56"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> is also divergent. Some studies found the diagnostic utility of this cytokine [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>] while others demonstrated similar or even lower levels in infected newborns compared to healthy newborns [<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>]. Discrepancies in results among different studies could be explained by the variations in laboratory methods in performing the analysis, the time of the sample collection, or the control population selected [<xref ref-type="bibr" rid="B28">28</xref>].</p><p>Interleukin-6 has been reported as an early indicator of neonatal sepsis because of its rapid increase after endotoxin challenge. IL-6 is secreted by monocytes and macrophages in response to bacteremia [<xref ref-type="bibr" rid="B31">31</xref>]. Previous studies have shown IL-6 to be a useful marker of early infection in the newborn [<xref ref-type="bibr" rid="B31">31</xref>&#x02013;<xref ref-type="bibr" rid="B34">34</xref>]. Kantar et al. [<xref ref-type="bibr" rid="B31">31</xref>] showed that septic preterm newborns had significantly elevated IL-6 levels at the onset of sepsis as compared to the recovery period and the controls. In our study, it was observed that IL-6 levels of newborn with culture-proven sepsis and culture-negative sepsis were significantly higher than controls (<inline-formula><mml:math id="M57"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula>).</p><p>Interleukin-8 is a cytokine that has a role in the release, activation, and chemotaxis of neutrophils. Serum IL-8 level has been reported to increase in neonatal sepsis and have a sensitivity of about 80&#x02013;90% and a specifity of about 76&#x02013;100% [<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>]. In this study, it was detected that IL-8 levels of newborns with culture-proven sepsis were significantly higher than culture-negative sepsis and controls (<inline-formula><mml:math id="M58"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula>). Kocabas et al. [<xref ref-type="bibr" rid="B37">37</xref>] and Martin et al. [<xref ref-type="bibr" rid="B17">17</xref>] found that IL-8 were higher in septic than in nonseptic newborns.</p><p>Another characteristic of the markers that are used in the diagnosis of neonatal sepsis is that it gives information about the prognosis of the disease and helps in coming to a decision as to whether to stop or continue antibiotic treatment. In this study, it is found that IL-1<inline-formula><mml:math id="M59"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M60"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels were statistically decreased in newborns after seven-day therapy than in newborns at the time of diagnosis (<inline-formula><mml:math id="M61"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula>). Similar results have been obtained in many studies [<xref ref-type="bibr" rid="B37">37</xref>&#x02013;<xref ref-type="bibr" rid="B39">39</xref>].</p></sec><sec sec-type="section" id="sec5"><title>5. CONCLUSION</title><p>Serum levels of IL-1<inline-formula><mml:math id="M62"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M63"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> are mediators of inflammation and can be used at the diagnosis and at the evaluation of the therapeutic efficiency in neonatal sepsis.</p></sec></body><back><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Volante</surname><given-names>E</given-names></name><name><surname>Moretti</surname><given-names>S</given-names></name><name><surname>Pisani</surname><given-names>F</given-names></name><name><surname>Bevilacqua</surname><given-names>G</given-names></name></person-group><article-title>Early diagnosis of bacterial infection in the neonate</article-title><source><italic>Journal of Maternal-Fetal &#x00026; Neonatal Medicine</italic></source><year>2004</year><volume>16</volume><issue>2</issue><fpage>13</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">15590427</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gladstone</surname><given-names>IM</given-names></name><name><surname>Ehrenkranz</surname><given-names>RA</given-names></name><name><surname>Edberg</surname><given-names>SC</given-names></name><name><surname>Baltimore</surname><given-names>RS</given-names></name></person-group><article-title>A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience</article-title><source><italic>Pediatric Infectious Disease Journal</italic></source><year>1990</year><volume>9</volume><issue>11</issue><fpage>819</fpage><lpage>825</lpage><pub-id pub-id-type="pmid">2263432</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vesikari</surname><given-names>R</given-names></name><name><surname>Janas</surname><given-names>M</given-names></name><name><surname>Gr&#x000f6;nroos</surname><given-names>P</given-names></name><etal/></person-group><article-title>Neonatal septicaemia</article-title><source><italic>Archives of Disease in Childhood</italic></source><year>1985</year><volume>60</volume><issue>6</issue><fpage>542</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">3925895</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kite</surname><given-names>P</given-names></name><name><surname>Millar</surname><given-names>MR</given-names></name><name><surname>Gorham</surname><given-names>P</given-names></name><name><surname>Congdon</surname><given-names>P</given-names></name></person-group><article-title>Comparison of five tests used in diagnosis of neonatal bacteraemia</article-title><source><italic>Archives of Disease in Childhood</italic></source><year>1988</year><volume>63</volume><issue>6</issue><fpage>639</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">3389893</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ainbender</surname><given-names>E</given-names></name><name><surname>Cabatu</surname><given-names>EE</given-names></name><name><surname>Guzman</surname><given-names>DM</given-names></name><name><surname>Sweet</surname><given-names>AY</given-names></name></person-group><article-title>Serum C-reactive protein and problems of newborn infants</article-title><source><italic>Journal of Pediatrics</italic></source><year>1982</year><volume>101</volume><issue>3</issue><fpage>438</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">7108668</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>O</given-names></name><name><surname>Ohlsson</surname><given-names>A</given-names></name><name><surname>Kenyon</surname><given-names>C</given-names></name></person-group><article-title>Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review</article-title><source><italic>Pediatric Infectious Disease Journal</italic></source><year>1995</year><volume>14</volume><issue>5</issue><fpage>1119</fpage><lpage>1120</lpage></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manroe</surname><given-names>BL</given-names></name><name><surname>Weinberg</surname><given-names>AG</given-names></name><name><surname>Rosenfeld</surname><given-names>CR</given-names></name><name><surname>Browne</surname><given-names>R</given-names></name></person-group><article-title>The neonatal blood count in health and disease. I. Reference values for neutrophilic cells</article-title><source><italic>Journal of Pediatrics</italic></source><year>1979</year><volume>95</volume><issue>1</issue><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">480023</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zipursky</surname><given-names>A</given-names></name><name><surname>Palko</surname><given-names>J</given-names></name><name><surname>Milner</surname><given-names>R</given-names></name><name><surname>Akenzua</surname><given-names>GI</given-names></name></person-group><article-title>The hematology of bacterial infections in premature infants</article-title><source><italic>Pediatrics</italic></source><year>1976</year><volume>57</volume><issue>6</issue><fpage>839</fpage><lpage>853</lpage><pub-id pub-id-type="pmid">934741</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mathers</surname><given-names>NJ</given-names></name><name><surname>Pohlandt</surname><given-names>F</given-names></name></person-group><article-title>Diagnostic audit of C-reactive protein in neonatal infection</article-title><source><italic>European Journal of Pediatrics</italic></source><year>1987</year><volume>146</volume><issue>2</issue><fpage>147</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">3569351</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sann</surname><given-names>L</given-names></name><name><surname>Bienvenu</surname><given-names>F</given-names></name><name><surname>Bienvenu</surname><given-names>J</given-names></name></person-group><article-title>Evolution of serum prealbumin, C-reactive protein, and orosomucoid in neonates with bacterial infection</article-title><source><italic>Journal of Pediatrics</italic></source><year>1984</year><volume>105</volume><issue>6</issue><fpage>977</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">6209373</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berner</surname><given-names>R</given-names></name><name><surname>Niemeyer</surname><given-names>CM</given-names></name><name><surname>Leititis</surname><given-names>JU</given-names></name><etal/></person-group><article-title>Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-<inline-formula><mml:math id="M64"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, interleukin (IL)-1<inline-formula><mml:math id="M65"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis</article-title><source><italic>Pediatric Research</italic></source><year>1998</year><volume>44</volume><issue>4</issue><fpage>469</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">9773833</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cairo</surname><given-names>MS</given-names></name></person-group><article-title>Neonatal neutrophil host defense. Prospects for immunologic enhancement during neonatal sepsis</article-title><source><italic>American Journal of Diseases of Children</italic></source><year>1989</year><volume>143</volume><issue>1</issue><fpage>40</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">2642645</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buck</surname><given-names>C</given-names></name><name><surname>Bundschu</surname><given-names>J</given-names></name><name><surname>Gallati</surname><given-names>H</given-names></name><name><surname>Bartmann</surname><given-names>P</given-names></name><name><surname>Pohlandt</surname><given-names>F</given-names></name></person-group><article-title>Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection</article-title><source><italic>Pediatrics</italic></source><year>1994</year><volume>93</volume><issue>1</issue><fpage>54</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">8265324</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Bont</surname><given-names>ES</given-names></name><name><surname>Martens</surname><given-names>A</given-names></name><name><surname>van Raan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Diagnostic value of plasma levels of tumor necrosis factor <inline-formula><mml:math id="M66"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> (TNF<inline-formula><mml:math id="M67"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>) and interleukin-6 (IL-6) in newborns with sepsis</article-title><source><italic>Acta Paediatrica</italic></source><year>1994</year><volume>83</volume><issue>7</issue><fpage>696</fpage><lpage>699</lpage><pub-id pub-id-type="pmid">7949797</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>MC</given-names></name><name><surname>Costarino</surname><given-names>AT</given-names><suffix>Jr.</suffix></name><name><surname>Sullivan</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis</article-title><source><italic>Journal of Pediatrics</italic></source><year>1994</year><volume>124</volume><issue>1</issue><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">8283358</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matthes</surname><given-names>T</given-names></name><name><surname>Werner-Favre</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Kindler</surname><given-names>V</given-names></name><name><surname>Zubler</surname><given-names>RH</given-names></name></person-group><article-title>Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor <inline-formula><mml:math id="M68"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, interleukin (IL)6, IL-10, and transforming growth factor <inline-formula><mml:math id="M69"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>1 mRNAs</article-title><source><italic>Journal of Experimental Medicine</italic></source><year>1993</year><volume>178</volume><issue>2</issue><fpage>521</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">8101860</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>H</given-names></name><name><surname>Olander</surname><given-names>B</given-names></name><name><surname>Norman</surname><given-names>M</given-names></name></person-group><article-title>Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-<inline-formula><mml:math id="M70"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> in the diagnosis of early-onset neonatal sepsis</article-title><source><italic>Pediatrics</italic></source><year>2001</year><volume>108</volume><issue>4</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11433046</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Philip</surname><given-names>AG</given-names></name><name><surname>Hewitt</surname><given-names>JR</given-names></name></person-group><article-title>Early diagnosis of neonatal sepsis</article-title><source><italic>Pediatrics</italic></source><year>1980</year><volume>65</volume><issue>5</issue><fpage>1036</fpage><lpage>1041</lpage><pub-id pub-id-type="pmid">7367117</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akenzua</surname><given-names>GI</given-names></name><name><surname>Hui</surname><given-names>YT</given-names></name><name><surname>Milner</surname><given-names>R</given-names></name><name><surname>Zipursky</surname><given-names>A</given-names></name></person-group><article-title>Neutrophil and band counts in the diagnosis of neonatal infections</article-title><source><italic>Pediatrics</italic></source><year>1974</year><volume>54</volume><issue>1</issue><fpage>38</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">4599473</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xanthou</surname><given-names>M</given-names></name></person-group><article-title>Leukocyte blood picture in ill newborn babies</article-title><source><italic>Archives of Disease in Childhood</italic></source><year>1972</year><volume>47</volume><issue>255</issue><fpage>741</fpage><lpage>743</lpage><pub-id pub-id-type="pmid">4563923</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manucha</surname><given-names>V</given-names></name><name><surname>Rusia</surname><given-names>U</given-names></name><name><surname>Sikka</surname><given-names>M</given-names></name><name><surname>Faridi</surname><given-names>MMA</given-names></name><name><surname>Madan</surname><given-names>N</given-names></name></person-group><article-title>Utility of haematological parameters and C-reactive protein in the detection of neonatal sepsis</article-title><source><italic>Journal of Paediatrics and Child Health</italic></source><year>2002</year><volume>38</volume><issue>5</issue><fpage>459</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">12354261</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fowlie</surname><given-names>PW</given-names></name><name><surname>Schmidt</surname><given-names>B</given-names></name></person-group><article-title>Diagnostic tests for bacterial infection from birth to 90 days&#x02014;a systematic review</article-title><source><italic>Archives of Disease in Childhood: Fetal and Neonatal Edition</italic></source><year>1998</year><volume>78</volume><issue>2</issue><fpage>F92</fpage><lpage>F98</lpage><pub-id pub-id-type="pmid">9577277</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>O</given-names></name><name><surname>Ohlsson</surname><given-names>A</given-names></name><name><surname>Kenyon</surname><given-names>C</given-names></name></person-group><article-title>Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review</article-title><source><italic>Pediatric Infectious Disease Journal</italic></source><year>1995</year><volume>14</volume><issue>5</issue><fpage>362</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">7638010</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saez-Llorens</surname><given-names>X</given-names></name><name><surname>Lagrutta</surname><given-names>SF</given-names></name></person-group><article-title>The acute phase host reaction during bacterial infection and its clinical impact in children</article-title><source><italic>Pediatric Infectious Disease Journal</italic></source><year>1993</year><volume>12</volume><issue>1</issue><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">8417431</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Bont</surname><given-names>ES</given-names></name><name><surname>Martens</surname><given-names>A</given-names></name><name><surname>van Raan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-<inline-formula><mml:math id="M71"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, interleukin-1<inline-formula><mml:math id="M72"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, and interleukin-6 plasma levels in neonatal sepsis</article-title><source><italic>Pediatric Research</italic></source><year>1993</year><volume>33</volume><issue>4, part 1</issue><fpage>380</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">8479819</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozdemir</surname><given-names>A</given-names></name><name><surname>Oygur</surname><given-names>N</given-names></name><name><surname>Gultekin</surname><given-names>M</given-names></name><name><surname>Coskun</surname><given-names>M</given-names></name><name><surname>Yegin</surname><given-names>O</given-names></name></person-group><article-title>Neonatal tumor necrosis factor, interleukin-1<inline-formula><mml:math id="M73"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, interleukin-1<inline-formula><mml:math id="M74"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, and interleukin-6 response to infection</article-title><source><italic>American Journal of Perinatology</italic></source><year>1994</year><volume>11</volume><issue>4</issue><fpage>282</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">7945622</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>PC</given-names></name><name><surname>Cheng</surname><given-names>SH</given-names></name><name><surname>Chui</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants</article-title><source><italic>Archives of Disease in Childhood: Fetal and Neonatal Edition</italic></source><year>1997</year><volume>77</volume><issue>3</issue><fpage>F221</fpage><lpage>F227</lpage><pub-id pub-id-type="pmid">9462194</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santana Reyes</surname><given-names>C</given-names></name><name><surname>Garc&#x000ed;a-Mu&#x000f1;oz</surname><given-names>F</given-names></name><name><surname>Reyes</surname><given-names>D</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>G</given-names></name><name><surname>Dominguez</surname><given-names>C</given-names></name><name><surname>Domenech</surname><given-names>E</given-names></name></person-group><article-title>Role of cytokines (interleukin-1<inline-formula><mml:math id="M75"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, 6, 8, tumour necrosis factor-<inline-formula><mml:math id="M76"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis</article-title><source><italic>Acta Paediatrica</italic></source><year>2003</year><volume>92</volume><issue>2</issue><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">12710650</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>LC</given-names></name><name><surname>Isa</surname><given-names>S</given-names></name><name><surname>LoPreste</surname><given-names>G</given-names></name><name><surname>Schaller</surname><given-names>JG</given-names></name><name><surname>Dinarello</surname><given-names>CA</given-names></name></person-group><article-title>Neonatal interleukin-1<inline-formula><mml:math id="M77"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>-, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production</article-title><source><italic>Journal of Pediatrics</italic></source><year>1990</year><volume>117</volume><issue>6</issue><fpage>961</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">2246700</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>JDM</given-names></name><name><surname>Wilson</surname><given-names>DC</given-names></name><name><surname>McMillan</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Predictive value of soluble immunological mediators in neonatal infection</article-title><source><italic>Clinical Science</italic></source><year>1994</year><volume>87</volume><issue>2</issue><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">7924161</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kantar</surname><given-names>M</given-names></name><name><surname>K&#x000fc;lt&#x000fc;rsay</surname><given-names>N</given-names></name><name><surname>K&#x000fc;t&#x000fc;k&#x000e7;&#x000fc;ler</surname><given-names>N</given-names></name><name><surname>Akis&#x000fc;</surname><given-names>M</given-names></name><name><surname>&#x000c7;eting&#x000fc;l</surname><given-names>N</given-names></name><name><surname>&#x000c7;aglayan</surname><given-names>S</given-names></name></person-group><article-title>Plasma concentrations of granulocyte-macrophage colony-stimulating factor and interleukin-6 in septic and healthy preterms</article-title><source><italic>European Journal of Pediatrics</italic></source><year>2000</year><volume>159</volume><issue>3</issue><fpage>156</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">10664226</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magudumana</surname><given-names>O</given-names></name><name><surname>Ballot</surname><given-names>DE</given-names></name><name><surname>Cooper</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Serial interleukin 6 measurements in the early diagnosis of neonatal sepsis</article-title><source><italic>Journal of Tropical Pediatrics</italic></source><year>2000</year><volume>46</volume><issue>5</issue><fpage>267</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">11077934</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lehrnbecher</surname><given-names>T</given-names></name><name><surname>Schrod</surname><given-names>L</given-names></name><name><surname>Kraus</surname><given-names>D</given-names></name><name><surname>Roos</surname><given-names>T</given-names></name><name><surname>Martius</surname><given-names>J</given-names></name><name><surname>von Stockhausen</surname><given-names>H-B</given-names></name></person-group><article-title>Interleukin-6 and soluble interleukin-6 receptor in cord blood in the diagnosis of early onset sepsis in neonates</article-title><source><italic>Acta Paediatrica</italic></source><year>1995</year><volume>84</volume><issue>7</issue><fpage>806</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">7549302</pub-id></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>MC</given-names></name><name><surname>Costarino</surname><given-names>AT</given-names><suffix>Jr.</suffix></name><name><surname>Sullivan</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis</article-title><source><italic>Journal of Pediatrics</italic></source><year>1994</year><volume>124</volume><issue>1</issue><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">8283358</pub-id></citation></ref><ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franz</surname><given-names>AR</given-names></name><name><surname>Steinbach</surname><given-names>G</given-names></name><name><surname>Kron</surname><given-names>M</given-names></name><name><surname>Pohlandt</surname><given-names>F</given-names></name></person-group><article-title>Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections</article-title><source><italic>Pediatrics</italic></source><year>1999</year><volume>104</volume><issue>3</issue><fpage>447</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">10469768</pub-id></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franz</surname><given-names>AR</given-names></name><name><surname>Steinbach</surname><given-names>G</given-names></name><name><surname>Kron</surname><given-names>M</given-names></name><name><surname>Pohlandt</surname><given-names>F</given-names></name></person-group><article-title>Interleukin-8: a valuable tool to restrict antibiotic therapy in newborn infants</article-title><source><italic>Acta Paediatrica</italic></source><year>2001</year><volume>90</volume><issue>9</issue><fpage>1025</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">11683191</pub-id></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kocaba&#x0015f;</surname><given-names>E</given-names></name><name><surname>Sarik&#x000e7;io&#x001e7;lu</surname><given-names>A</given-names></name><name><surname>Aksaray</surname><given-names>N</given-names></name><name><surname>Seydao&#x001e7;lu</surname><given-names>G</given-names></name><name><surname>Seyhun</surname><given-names>Y</given-names></name><name><surname>Yaman</surname><given-names>A</given-names></name></person-group><article-title>Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-<inline-formula><mml:math id="M78"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> in the diagnosis of neonatal sepsis</article-title><source><italic>Turkish Journal of Pediatrics</italic></source><year>2007</year><volume>49</volume><issue>1</issue><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">17479639</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>J</given-names></name><name><surname>Eyer</surname><given-names>D</given-names></name><name><surname>Donato</surname><given-names>L</given-names></name><name><surname>Gallati</surname><given-names>H</given-names></name><name><surname>Martis</surname><given-names>J</given-names></name><name><surname>Simeoni</surname><given-names>U</given-names></name></person-group><article-title>Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection</article-title><source><italic>Journal of Pediatrics</italic></source><year>1996</year><volume>129</volume><issue>4</issue><fpage>574</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">8859265</pub-id></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oberhoffer</surname><given-names>M</given-names></name><name><surname>Vogelsang</surname><given-names>H</given-names></name><name><surname>Ru&#x000df;wurm</surname><given-names>S</given-names></name><name><surname>Hartung</surname><given-names>T</given-names></name><name><surname>Reinhart</surname><given-names>K</given-names></name></person-group><article-title>Outcome prediction by traditional and new markers of inflammation in patients with sepsis</article-title><source><italic>Clinical Chemistry and Laboratory Medicine</italic></source><year>1999</year><volume>37</volume><issue>3</issue><fpage>363</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">10353484</pub-id></citation></ref></ref-list></back><floats-wrap><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>Characteristics of the study groups.</p></caption><table><thead><tr><th align="center" rowspan="1" colspan="1">Character</th><th align="center" rowspan="1" colspan="1">Culture-proven sepsis (<inline-formula><mml:math id="M79" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>12</mml:mn></mml:mrow></mml:math></inline-formula>)</th><th align="center" rowspan="1" colspan="1">Culture-negative sepsis (<inline-formula><mml:math id="M80" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>21</mml:mn></mml:mrow></mml:math></inline-formula>)</th><th align="center" rowspan="1" colspan="1">Controls (<inline-formula><mml:math id="M81" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>17</mml:mn></mml:mrow></mml:math></inline-formula>)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Gender M/F</td><td align="center" rowspan="1" colspan="1">8/4</td><td align="center" rowspan="1" colspan="1">9/13</td><td align="center" rowspan="1" colspan="1">8/9</td></tr><tr><td rowspan="1" colspan="1">Weight(g)</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M82" overflow="scroll"><mml:mrow><mml:mn>2033</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>938</mml:mn></mml:mrow></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M83" overflow="scroll"><mml:mrow><mml:mn>2111</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>975</mml:mn></mml:mrow></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M84" overflow="scroll"><mml:mrow><mml:mn>2294</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>761</mml:mn></mml:mrow></mml:math></inline-formula></td></tr><tr><td rowspan="1" colspan="1">Gestational age (weeks)</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M85" overflow="scroll"><mml:mn>34.2</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>4.0</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M86" overflow="scroll"><mml:mn>34.0</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>3.3</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M87" overflow="scroll"><mml:mn>35.3</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>2.6</mml:mn></mml:math></inline-formula></td></tr></tbody></table></table-wrap><table-wrap position="float" id="tab2"><label>Table 2</label><caption><p>Serum IL-1<inline-formula><mml:math id="M88" overflow="scroll"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, IL-6, IL-8, and TNF-<inline-formula><mml:math id="M89" overflow="scroll"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> levels of the study groups.</p></caption><table><thead><tr><th colspan="2" align="center" rowspan="1">Serum cytokine levels</th><th align="center" rowspan="1" colspan="1">Culture-proven sepsis<sup>a</sup> (<inline-formula><mml:math id="M90" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>12</mml:mn></mml:mrow></mml:math></inline-formula>)</th><th align="center" rowspan="1" colspan="1">Culture-negative sepsis<sup>b</sup> (<inline-formula><mml:math id="M91" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>21</mml:mn></mml:mrow></mml:math></inline-formula>)</th><th align="center" rowspan="1" colspan="1">Controls<sup>c</sup> (<inline-formula><mml:math id="M92" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>17</mml:mn></mml:mrow></mml:math></inline-formula>)</th><th align="center" rowspan="1" colspan="1">*<italic>P</italic> value <inline-formula><mml:math id="M93" overflow="scroll"><mml:mrow><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula></th></tr></thead><tbody><tr><td rowspan="2" colspan="1"> IL-1<inline-formula><mml:math id="M94" overflow="scroll"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> (pg/mL)</td><td align="left" rowspan="1" colspan="1">At time of diagnosis<sup>1</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M95" overflow="scroll"><mml:mn>41.20</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>13.57</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M96" overflow="scroll"><mml:mn>33.30</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>8.62</mml:mn></mml:math></inline-formula></td><td rowspan="2" align="center" colspan="1"><inline-formula><mml:math id="M97" overflow="scroll"><mml:mn>10.35</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>2.65</mml:mn></mml:math></inline-formula></td><td rowspan="2" align="center" colspan="1">a-c, b-c</td></tr><tr><td align="center" rowspan="1" colspan="1">7th day<sup>2</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M98" overflow="scroll"><mml:mn>10.87</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>4.49</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M99" overflow="scroll"><mml:mn>9.47</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>3.53</mml:mn></mml:math></inline-formula></td></tr><tr><td rowspan="2" colspan="1"> IL-6 (pg/mL)</td><td align="left" rowspan="1" colspan="1">At time of diagnosis<sup>1</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M100" overflow="scroll"><mml:mn>193.95</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>74.11</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M101" overflow="scroll"><mml:mn>155.42</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>70.06</mml:mn></mml:math></inline-formula></td><td rowspan="2" align="center" colspan="1"><inline-formula><mml:math id="M102" overflow="scroll"><mml:mn>8.19</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>5.84</mml:mn></mml:math></inline-formula></td><td rowspan="2" align="center" colspan="1">a-c, b-c</td></tr><tr><td align="center" rowspan="1" colspan="1">7th day<sup>2</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M103" overflow="scroll"><mml:mn>9.45</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>6.96</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M104" overflow="scroll"><mml:mn>8.99</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>6.08</mml:mn></mml:math></inline-formula></td></tr><tr><td rowspan="2" colspan="1"> IL-8 (pg/mL)</td><td align="left" rowspan="1" colspan="1">At time of diagnosis<sup>1</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M105" overflow="scroll"><mml:mn>481.33</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>186.58</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M106" overflow="scroll"><mml:mn>376.85</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>96.61</mml:mn></mml:math></inline-formula></td><td rowspan="2" align="center" colspan="1"><inline-formula><mml:math id="M107" overflow="scroll"><mml:mn>55.51</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>26.54</mml:mn></mml:math></inline-formula></td><td rowspan="2" align="center" colspan="1">a-b, a-c, b-c</td></tr><tr><td align="center" rowspan="1" colspan="1">7th day<sup>2</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M108" overflow="scroll"><mml:mn>89.41</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>57.69</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M109" overflow="scroll"><mml:mn>53.57</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>34.84</mml:mn></mml:math></inline-formula></td></tr><tr><td rowspan="2" colspan="1"> TNF-<inline-formula><mml:math id="M110" overflow="scroll"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> (pg/mL)</td><td align="left" rowspan="1" colspan="1">At time of diagnosis<sup>1</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M111" overflow="scroll"><mml:mn>21.00</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>9.43</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M112" overflow="scroll"><mml:mn>17.64</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>6.70</mml:mn></mml:math></inline-formula></td><td rowspan="2" align="center" colspan="1"><inline-formula><mml:math id="M113" overflow="scroll"><mml:mn>4.55</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>1.52</mml:mn></mml:math></inline-formula></td><td rowspan="2" align="center" colspan="1">a-c, b-c</td></tr><tr><td align="center" rowspan="1" colspan="1">7th day<sup>2</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M114" overflow="scroll"><mml:mn>5.23</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>1.74</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M115" overflow="scroll"><mml:mn>4.92</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>1.68</mml:mn></mml:math></inline-formula></td></tr><tr><td rowspan="1" colspan="1">**<italic>P</italic> value </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><inline-formula><mml:math id="M116" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1-2</td><td align="center" rowspan="1" colspan="1">1-2</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr></tbody></table><table-wrap-foot><fn><p>* Kruskal Wallis test.</p></fn><fn><p>** Wilcoxon test.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 